What are the typical treatment plans and follow-up strategies for common primary care diagnoses, including hypertension, type 2 diabetes, respiratory infections, and asthma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Primary Care Follow-Up Visits with Treatment Plans and Diagnoses

The most effective primary care follow-up visits should include comprehensive assessment, targeted treatment plans, and clear follow-up strategies tailored to specific conditions like hypertension, diabetes, respiratory infections, and asthma. Based on current guidelines, I'll outline 12 patient follow-up scenarios with evidence-based treatment plans.

Hypertension Management

Patient 1: Newly Diagnosed Stage 1 Hypertension (BP 135/85 mmHg)

  • Diagnosis: Stage 1 Hypertension
  • Treatment Plan:
    • Lifestyle modifications as first-line therapy: weight reduction, DASH diet, sodium restriction (<2.3g/day), physical activity (150 min/week), and alcohol moderation 1
    • Schedule follow-up in 3-6 months to reassess BP control 1
    • Home BP monitoring with proper technique (2 readings 1 minute apart, morning and evening) 1
    • Calculate ASCVD risk to determine if medication is needed despite Stage 1 classification 1
  • Follow-up Strategy: Monthly BP checks until target achieved, then every 3-6 months 1

Patient 2: Uncontrolled Stage 2 Hypertension (BP 160/95 mmHg)

  • Diagnosis: Stage 2 Hypertension
  • Treatment Plan:
    • Initiate two-drug combination therapy: ACE inhibitor/ARB plus calcium channel blocker or thiazide-like diuretic 1
    • Specific medication: Lisinopril 10mg daily, titrate to 20-40mg as needed 2
    • Continue lifestyle modifications with emphasis on sodium restriction and weight loss 1
    • Monitor electrolytes and renal function 2-4 weeks after initiating RAS inhibitors 1
  • Follow-up Strategy: Reassess in 2-4 weeks to adjust medication dosage until BP control achieved 1

Patient 3: Hypertension with Comorbid Diabetes (BP 142/88 mmHg)

  • Diagnosis: Hypertension with Type 2 Diabetes
  • Treatment Plan:
    • Target BP <130/80 mmHg 1
    • Initiate RAS inhibitor (ACE inhibitor or ARB) plus CCB or thiazide-like diuretic 1
    • Add statin therapy based on LDL levels (target <70 mg/dL if target organ damage present) 1
    • Comprehensive diabetes management with glucose monitoring and HbA1c target <7% 1
  • Follow-up Strategy: Monthly visits until BP target achieved, then quarterly monitoring of BP, renal function, and glycemic control 1

Diabetes Management

Patient 4: Newly Diagnosed Type 2 Diabetes (HbA1c 7.8%)

  • Diagnosis: Type 2 Diabetes Mellitus
  • Treatment Plan:
    • Initiate metformin 500mg daily, titrate to 1000mg twice daily as tolerated
    • Comprehensive diabetes education including self-monitoring of blood glucose
    • Dietary counseling with carbohydrate counting and portion control
    • Target HbA1c <7% 1
    • Screen for microalbuminuria and initiate ACE inhibitor if positive 1
  • Follow-up Strategy: Reassess in 3 months with HbA1c, comprehensive metabolic panel, and urine microalbumin

Patient 5: Poorly Controlled Type 2 Diabetes (HbA1c 9.2%)

  • Diagnosis: Uncontrolled Type 2 Diabetes Mellitus
  • Treatment Plan:
    • Intensify therapy with addition of second-line agent (GLP-1 agonist or SGLT2 inhibitor)
    • Review medication adherence and address barriers
    • Refer to diabetes educator for reinforcement of self-management skills
    • Screen for complications (retinopathy, neuropathy, nephropathy)
    • Assess cardiovascular risk and consider statin therapy 1
  • Follow-up Strategy: Monthly visits until glycemic improvement, then quarterly HbA1c monitoring

Respiratory Infection Management

Patient 6: Acute Bronchitis

  • Diagnosis: Acute Bronchitis
  • Treatment Plan:
    • Symptomatic treatment with antitussives for cough
    • Hydration and rest
    • Avoid antibiotic therapy unless evidence of bacterial infection
    • Short-acting bronchodilator if wheezing present (albuterol as needed) 3
    • Patient education on expected course (symptoms may last 2-3 weeks)
  • Follow-up Strategy: Return in 7-10 days if symptoms worsen or fail to improve

Patient 7: Community-Acquired Pneumonia (Outpatient)

  • Diagnosis: Community-Acquired Pneumonia
  • Treatment Plan:
    • Antibiotic therapy based on local resistance patterns (amoxicillin or doxycycline)
    • Adequate hydration and rest
    • Antipyretics for fever
    • Supplemental oxygen if oxygen saturation <92%
    • Smoking cessation counseling if applicable 1
  • Follow-up Strategy: Clinical reassessment in 48-72 hours, follow-up chest X-ray in 6 weeks for patients >50 years or with persistent symptoms

Patient 8: Upper Respiratory Tract Infection

  • Diagnosis: Upper Respiratory Tract Infection
  • Treatment Plan:
    • Symptomatic relief with saline nasal irrigation, decongestants
    • Adequate hydration and rest
    • Avoid unnecessary antibiotics
    • Patient education on viral etiology and expected duration
    • Return precautions for worsening symptoms
  • Follow-up Strategy: Return as needed if symptoms worsen or persist beyond 10-14 days

Asthma Management

Patient 9: Mild Persistent Asthma

  • Diagnosis: Mild Persistent Asthma
  • Treatment Plan:
    • Low-dose inhaled corticosteroid (fluticasone) as controller medication 4
    • Short-acting beta-agonist (albuterol) as rescue medication 3
    • Asthma action plan with peak flow monitoring
    • Trigger avoidance education
    • Proper inhaler technique instruction
  • Follow-up Strategy: Reassess in 4-6 weeks, then every 3-6 months if well-controlled

Patient 10: Moderate Persistent Asthma with Exacerbation

  • Diagnosis: Moderate Persistent Asthma with Acute Exacerbation
  • Treatment Plan:
    • Short course of oral corticosteroids (prednisone 40mg daily for 5 days)
    • Increase inhaled corticosteroid dose temporarily
    • Add long-acting beta-agonist if not already prescribed
    • Review and adjust asthma action plan
    • Assess adherence and inhaler technique 4
  • Follow-up Strategy: Reassess in 1-2 weeks after exacerbation, then monthly until stable

Patient 11: Hypertension with Asthma (BP 148/92 mmHg)

  • Diagnosis: Hypertension with Comorbid Asthma
  • Treatment Plan:
    • Avoid beta-blockers for hypertension management
    • Prefer calcium channel blocker and/or ACE inhibitor/ARB for BP control 1
    • Maintain asthma controller therapy with inhaled corticosteroids 4
    • Monitor for drug interactions between antihypertensives and asthma medications
    • Emphasize importance of adherence to both medication regimens
  • Follow-up Strategy: Monthly visits until both conditions are controlled, then quarterly follow-up

Patient 12: Elderly Patient with Multiple Chronic Conditions (Hypertension, Type 2 Diabetes, COPD)

  • Diagnosis: Multiple Chronic Conditions (Hypertension, Type 2 Diabetes, COPD)
  • Treatment Plan:
    • Simplify medication regimen where possible to improve adherence
    • Target BP <140/80 mmHg (less aggressive in elderly) 1
    • Diabetes management with HbA1c target <8% (less stringent in elderly with comorbidities)
    • COPD management with appropriate inhaler therapy
    • Comprehensive medication review to avoid interactions
    • Fall risk assessment and prevention strategies
  • Follow-up Strategy: Monthly visits initially, then every 2-3 months once stable

Common Pitfalls to Avoid in Primary Care Follow-Up

  • Therapeutic inertia: Failure to intensify therapy when targets are not met 1
  • Inadequate follow-up intervals: Too infrequent monitoring during medication adjustment periods 1
  • Overlooking medication adherence: Critical to assess at each visit 1
  • Neglecting lifestyle modifications: These remain fundamental even when medications are needed 1, 5
  • Missing secondary causes of hypertension: Especially important in young adults or resistant hypertension 6
  • Ignoring home monitoring data: Home BP and glucose readings provide valuable information between visits 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Newly Diagnosed Hypertension in Young Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.